<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-NRZOZDJ2/87ab80c5-d29f-4f44-862c-e68d7b18aef7/PDF"><dcterms:extent>292 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-NRZOZDJ2/f89346a6-6940-4e5e-a60f-0483ae4bee83/TEXT"><dcterms:extent>34 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-NRZOZDJ2"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:SPR-WQVGMCSC" /><dcterms:issued>2006</dcterms:issued><dc:creator>Kazanowska, Bernarda</dc:creator><dc:creator>Reich, Adam</dc:creator><dc:creator>Wróbel, Grazyna</dc:creator><dc:format xml:lang="sl">letnik:15</dc:format><dc:format xml:lang="sl">številka:4</dc:format><dc:format xml:lang="sl">str. 158-168</dc:format><dc:identifier>ISSN:1318-4458</dc:identifier><dc:identifier>COBISSID_HOST:22327257</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-NRZOZDJ2</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Slovene Welding Society</dc:publisher><dcterms:isPartOf xml:lang="sl">Acta dermatovenerologica Alpina, Pannonica et Adriatica</dcterms:isPartOf><dc:subject xml:lang="en">Diagnosis</dc:subject><dc:subject xml:lang="sl">Kožne manifestacije</dc:subject><dc:subject xml:lang="sl">Kožne novotvorbe</dc:subject><dc:subject xml:lang="en">Lymphoma, Non-Hodgkin's</dc:subject><dc:subject xml:lang="en">Neoplasm Staging</dc:subject><dc:subject xml:lang="sl">Novotvorba, stadij</dc:subject><dc:subject xml:lang="en">Pathology</dc:subject><dc:subject xml:lang="sl">Preživetje, analiza</dc:subject><dc:subject xml:lang="en">Retrospective Studies</dc:subject><dc:subject xml:lang="sl">Retrospektivne študije</dc:subject><dc:subject xml:lang="en">Skin Manifestations</dc:subject><dc:subject xml:lang="en">Skin Neoplasms</dc:subject><dc:subject xml:lang="en">Survival Analysis</dc:subject><dc:subject xml:lang="en">Therapy</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Skin involvement in highly malignant non-Hodgkin lymphomas of childhood and adolescence|</dc:title><dc:description xml:lang="sl">Objective: The aim of this study was to demonstrate the clinical spectrum of highly malignant cutaneous non-Hodgkin lymphoma (NHL) in children and to define the outcome among these patients. Material and methods: A retrospectiveanalysis of children with NHL treated at Polish oncology centers was carried out in order to determine patients with skin involvement. Thirteensubjects with primary and 4 with secondary cutaneous NHL were studied.The diagnosis of NHL was based on histological and immunohistochemicalexamination of skin biopsy. Results: Nine of 13 cases of primary cutaneous NHL presented as a tumors. Other manifestations were as follows: hard infiltration, edema of subcutaneous tissue, maculopapular lesions, and generalized erythroderma. The mean time between the first cutaneous symptoms and diagnosis of NHL was 5.6 +_ 3.3 months. Secondary cutaneous lesions during the course of NHL were described as maculopapular or nodular eruption. In addition, 2 subjects had generalized ichthyosis. Among patients with primary cutaneous NHL, 11 (84.6%) subjects are still alive without any signs of the disease. Two children (15.4°/o) died. In patients with secondary skin involvement during the course of NHL only one child is still alive with a residual tumor mass in the mediastinum. The estimated 5-year overall survival for primary cutaneous NHL was significantly better than for individuals with secondary cutaneous NHL (p = 0.02). Conclusions: Primary cutaneous NHL has a relatively favorable prognosis. On the other hand,cutaneous metastases of extracutaneous NHL seem to be a poor prognostic factor</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-NRZOZDJ2"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-NRZOZDJ2" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-NRZOZDJ2/87ab80c5-d29f-4f44-862c-e68d7b18aef7/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Združenje slovenskih dermatovenerologov</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-NRZOZDJ2/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-NRZOZDJ2" /></ore:Aggregation></rdf:RDF>